State Of Wyoming Immatics N.V. Transaction History

State Of Wyoming

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$6.74 - $9.44 $2,460 - $3,445	-365 Reduced 3.33%	10,610 $73,000
Q4 2022 Feb 14, 2023	BUY	$8.05 - $11.58 $88,348 - $127,090	10,975 New	10,975 $95,000
Q2 2022 Aug 15, 2022	SELL	$6.0 - $9.37 $3,558 - $5,556	-593 Reduced 61.2%	376 $3,000
Q1 2022 May 13, 2022	BUY	$6.64 - $12.85 $1,733 - $3,353	261 Added 36.86%	969 $8,000
Q4 2021 Feb 11, 2022	BUY	$10.81 - $14.38 $929 - $1,236	86 Added 13.83%	708 $10,000
Q3 2021 Feb 11, 2022	SELL	$11.58 - $15.46 $4,064 - $5,426	-351 Reduced 36.07%	622 $8,000
Q2 2021 Feb 11, 2022	BUY	$10.43 - $12.81 $10,148 - $12,464	973 New	973 $11,000

76.6M

571K

210K

Ticker IMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,227,000
Market Cap $894M
Description
Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.